drugset / Trial / NCT06479616

A Long-term Follow-up Study in Participants Who Received CS-101

NCT06479616 ↗

NaSingle-groupOpen-labelOther

Summary

This is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-03 (NCT06065189)

Timeline

Start
2024-06-18
Primary completion
2026-12
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject CS-101 Cell therapy — —

Indications